AI Article Synopsis

  • An 82-year-old woman with primary biliary cholangitis developed irreversible neurological issues due to metronidazole (MNZ), a common antibiotic.
  • While MNZ-induced encephalopathy is typically reversible, it can lead to severe complications or even death in rare instances.
  • Doctors should exercise caution when prescribing medications, especially for patients needing high doses over long periods or those with liver problems.

Article Abstract

An 82-year-old woman with primary biliary cholangitis was diagnosed with an irreversible neurological disorder, caused by metronidazole (MNZ)-induced encephalopathy. Although the disorder is a reversible pathological condition, in rare cases, it can cause serious sequelae or could even be fatal. Therefore, medications should be administered carefully, particularly in patients who require long-term administration of large doses or those with liver dysfunction.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729387PMC
http://dx.doi.org/10.1002/jgf2.91DOI Listing

Publication Analysis

Top Keywords

woman primary
8
primary biliary
8
biliary cholangitis
8
irreversible metronidazole
4
metronidazole encephalopathy
4
encephalopathy elderly
4
elderly woman
4
cholangitis 82-year-old
4
82-year-old woman
4
cholangitis diagnosed
4

Similar Publications

Background: Limited studies have explored the relationship between estimated Glomerular Filtration Rate(eGFR) and in-hospital mortality(IHM) in low-income sub-Saharan African countries. This study aimed to explores this association, offering insights into its impact in resource-limited settings.

Methods And Results: We retrospectively included 226 patients(age 45.

View Article and Find Full Text PDF

Unlabelled: Sickle cell disease (SCD) is a global health problem causing premature deaths and preventable severe chronic complications. A priority goal to improve outcomes both in the short and long term is the screening for early diagnosis and access to specialized care. In Italy, as in other countries, no systematic national screening program is available.

View Article and Find Full Text PDF

Ductal carcinoma in situ (DCIS) may progress to ipsilateral invasive breast cancer (iIBC), but often never will. Because DCIS is treated as early breast cancer, many women with harmless DCIS face overtreatment. To identify features associated with progression, we developed an artificial intelligence-based DCIS morphometric analysis pipeline (AIDmap) on hematoxylin-eosin-stained (H&E) tissue sections.

View Article and Find Full Text PDF

Optimizing Diabetes-in-Pregnancy Outcomes Requires a Care Continuum.

Am J Perinatol

January 2025

Center for Advanced Research Training and Innovation, Center for Birth Defects Research, University of Maryland School of Medicine, Baltimore, Maryland.

This study aimed to assess the strengths, limitations, opportunities, and threats presented by diabetes-in-pregnancy. We review the improvements in maternal and fetal mortality since the advent of insulin therapy, evaluate current health challenges, and identify opportunities for preventing increased mortality due to diabetes-in-pregnancy. Prior to 1922, women with type 1 diabetes mellitus (T1DM) of childbearing age were discouraged from becoming pregnant as the maternal and fetal/neonatal mortality rates were extremely high.

View Article and Find Full Text PDF

Monitoring of inflammatory preterm responses via myometrial cell based multimodal electrophysiological and optical biosensing platform.

Biosens Bioelectron

January 2025

Department of Chemistry, ZJU-Hangzhou Global Scientific and Technological Innovation Center, School of Medicine, Zhejiang University, Hangzhou, 310058, China; General Surgery Department, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children's Health, Hangzhou, 310052, China. Electronic address:

Preterm birth (PTB) remains a leading cause of neonatal morbidity and mortality, with inflammation-induced PTB posing a significant challenge due to its complex pathophysiology. To address this, we developed an in vitro platform utilizing hTERT-immortalized human myometrial (hTERT-HM) cells integrated with a multielectrode array (MEA) biosensing system and optical calcium imaging. Compared to primary uterine myometrial cells, hTERT-HM cells exhibit superior reproducibility, high scalability, and convenient manipulation, facilitating the consistent and large-scale investigations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!